tm logo

Monitor this mark

View On USPTO

SETEVRI
Live/Pending
NON-FINAL ACTION - MAILED

final action

on 02 Sep 2024

Last Applicant/ Owned by

DAIICHI SANKYO COMPANY, LIMITED

Chuo-ku Tokyo 103-8426

XP

Serial Number

79400277 filed on 03rd Jun 2024

Registration Number

N/A

Correspondent Address

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

SETEVRI

Pharmaceutical preparations for the treatment and prevention of cancer, oncological diseases, leukemia, pseudoxanthoma, systemic lupus erythematosus, cardiovascular diseases, kidney diseases, Netherton syndrome.

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the treatment and prevention of cancer, oncological diseases, leukemia, pseudoxanthoma, systemic lupus erythematosus, cardiovascular diseases, kidney diseases, Netherton syndrome.

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 79400277

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History

Status DateAction Taken
30th Sep 2024REFUSAL PROCESSED BY IB
02th Sep 2024REFUSAL PROCESSED BY MPU
02th Sep 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
31st Aug 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
30th Aug 2024NON-FINAL ACTION WRITTEN
22nd Aug 2024ASSIGNED TO EXAMINER
26th Jul 2024APPLICATION FILING RECEIPT MAILED
26th Jul 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
25th Jul 2024LIMITATION FROM ORIGINAL APPLICATION ENTERED
18th Jul 2024SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB